CD8A and acute myeloid leukemia: A research study on primary human acute myeloid leukemia showed that HLA-DBP1 specific TCRs genetic transfer into CD4+ and CD8+ T cells could provide an enhanced immune reaction to AML blasts via cytolytic activity and IFN-gamma production in the AML xenograft mouse model19.